Prevalence of white coat effect in treated hypertensive patients in the community.
about
Automated office blood pressure measurement in primary careClinical problem solving based on the 1999 Canadian recommendations for the management of hypertension.1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of HypertensionA novel approach to office blood pressure measurement: 30-minute office blood pressure vs daytime ambulatory blood pressure.Level of blood pressure above goal and clinical inertia in a Medicaid population.Diagnosis and treatment of high blood pressure. New directions and new approaches: 1999 Canadian recommendations for management of hypertensionScreening for hypertension annually compared with current practice.IMPPACT: Investigation of Medical Professionals and Patients Achieving Control Together.Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An updateDoctors record higher blood pressures than nurses: systematic review and meta-analysis.Replacing manual sphygmomanometers with automated blood pressure measurement in routine clinical practice.Clinical Implications of Different Blood Pressure Measurement Techniques.Comparison of manual versus automated blood pressure measurement in intensive care unit, coronary care unit, and emergency room.BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols.Talking effect and "white coat" effect in hypertensive patients: physical effort or emotional content?Deep breathing: A simple test for white coat effect detection in primary care.Automated Office Blood Pressure Measurement.The Post Clinic Ambulatory Blood Pressure (PC-ABP) study correlates Post Clinic Blood Pressure (PCBP) with the gold standard Ambulatory Blood Pressure.
P2860
Q26824815-34CC9BD7-3644-46D8-A9D3-FDAC4208E44AQ30499043-8A20445B-AAA3-4540-BEEA-698451C8A556Q30499045-4E6C3896-F962-4AE8-ABD8-90762EDDCE70Q34669142-615041AB-9732-4E42-96B4-3BCA793DC17AQ35070931-659D2D3C-0CA8-4710-BFD6-9DE2097FA70BQ36282431-064EF866-82F7-49B3-85DD-4859D1C624B7Q36695691-7C21074E-39FE-4551-B32B-EEC2FE16B52DQ37113379-C056655E-39A1-4AC0-87F8-4E113161CBCBQ37384476-3FB7F8EB-4BEE-41B9-8F2F-5CE67C831461Q37660811-F0CE8A26-BEFB-48AC-AA73-F56D1C531218Q38118785-A296CD94-5E6B-4BD6-B33B-006555A64B2DQ39334583-B130A92E-5303-4708-890B-2BC7788104B2Q41046053-CA073E8F-3670-4F69-BA0A-ECDEA6F0A511Q46120095-8BFBD1AE-0D3E-4FA6-8925-16BE595D7C35Q51065433-6547217C-46D0-446A-B17E-F9697C8D5C19Q51665220-C9B5816E-A753-40CF-86F3-2AFC56BEC0C0Q55403823-D8D1E4C9-7F10-49F9-9432-7CC9D1AD0C25Q55657765-B4C34079-8DCB-4990-AAAC-58423356849D
P2860
Prevalence of white coat effect in treated hypertensive patients in the community.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Prevalence of white coat effect in treated hypertensive patients in the community.
@en
Prevalence of white coat effect in treated hypertensive patients in the community.
@nl
type
label
Prevalence of white coat effect in treated hypertensive patients in the community.
@en
Prevalence of white coat effect in treated hypertensive patients in the community.
@nl
prefLabel
Prevalence of white coat effect in treated hypertensive patients in the community.
@en
Prevalence of white coat effect in treated hypertensive patients in the community.
@nl
P2093
P1476
Prevalence of white coat effect in treated hypertensive patients in the community.
@en
P2093
P304
P356
10.1016/0895-7061(95)00049-U
P577
1995-06-01T00:00:00Z